Zanidatamab Combined with Chemotherapy

DRUG2 trials

Sponsors

Xijing Hospital, Universitaire Ziekenhuizen KU Leuven

Conditions

Gastric/Gastroesophageal Junction AdenocarcinomaGastroesophageal Cancer

Phase 1

Perioperative Zanidatamab and Chemotherapy for HER2 Positive Gastroesophageal Cancer

Not yet recruitingNCT07477444

Universitaire Ziekenhuizen KU LeuvenGastroesophageal Cancer

Start: 2026-06-01End: 2033-06-01Target: 29Updated: 2026-03-20

Phase 2

Zanidatamab Combined With Chemotherapy as Neoadjuvant Therapy for HER2-high Expression G/GEJC

Not yet recruitingNCT07273981

Xijing HospitalGastric/Gastroesophageal Junction Adenocarcinoma

Start: 2026-01-01End: 2029-07-31Target: 30Updated: 2025-12-10